Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16874
Country/Region: Tanzania
Year: 2015
Main Partner: Tanzania Health Promotion Support
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $6,618,166 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $143,352
Care: Pediatric Care and Support (PDCS) $227,124
Laboratory Infrastructure (HLAB) $265,000
Sexual Prevention: Other Sexual Prevention (HVOP) $159,402
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $400,664
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $1,553,968
Treatment: Adult Treatment (HTXS) $3,641,532
Treatment: Pediatric Treatment (PDTX) $227,124
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 59,764
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 16,314
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 275,381
LAB_ACC Number of PEPFAR-supported testing facilities (laboratories) that are recognized by national, regional, or international standards for accreditation or have achieved a minimal acceptable level towards attainment of such accreditation 2016 1
LAB_CAP By clinical laboratories 2016 68
LAB_CAP By Point-of-care testing sites 2016 32
LAB_CAP Number of PEPFAR-supported testing facilities with capacity to perform clinical laboratory tests 2016 100
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 1,122
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 527
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 595
PMTCT_ARV Sum of New and Current disaggregates 2016 1,122
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 805
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 348
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 1,153
PMTCT_EID Sum of Infant Age disaggregates 2016 1,153
PMTCT_STAT By: Known positives at entry 2016 521
PMTCT_STAT By: Number of new positives identified 2016 918
PMTCT_STAT Number of new ANC and L&D clients 2016 28,747
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 28,747
PMTCT_STAT Sum of Positives Status disaggregates 2016 1,439
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 59,764
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 56,775
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 55,446
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 20,959
Cross Cutting Budget Categories and Known Amounts Total: $1,191,673
Human Resources for Health $500,000
Key Populations: MSM and TG $50,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $50,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Gender: Gender Based Violence (GBV) $525,673
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $66,000
Increase gender-equitable access to income and productive resources, including education
Collection and Use of Gender-related Strategic Information
Implementation
Monitoring and Evaluation
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Implementation
Monitoring and Evaluation